Project Grant K01AI182449

Award Date 8/1/24
Completion Date 7/31/29
Dollars Obligated $444K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Sacramento, CA 95817, USA
Similar Awards
This Cooperative Agreement award for $7,013,600 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program aims to develop reliable methods for predicting neurodevelopmental outcomes, such as autism and ADHD, in children exposed to maternal infections during pregnancy. The study will leverage electronic health records data from over 150,000 maternal-offspring dyads across two health systems to characterize maternal infections, pregnancy...
This federal Project Grant award of $418,178 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to provide mechanistic insights into the neurobiological mechanisms by which maternal sensitivity is compromised by postpartum depression. Specifically, the University of Massachusetts (UMass), through its Office of Grant & Contract Administration, will use intersectional viral...
This $5.1 million project grant from the National Institute of Mental Health (NIMH), part of the Department of Health and Human Services, supports research under the Mental Health Research Grants program (CFDA 93.242). The Massachusetts General Hospital will utilize its existing biobank of over 800 maternal blood and neonatal cord blood samples linked to clinical records to characterize the impact of maternal SARS-CoV-2 infection on fetal neurodevelopment. Researchers will analyze immune...
The National Institute of Child Health and Human Development (NICHD) awarded a $431,750 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Rutgers, The State University of New Jersey, to investigate how the cytokine interleukin-6 (IL-6) affects the proliferation, specification and gene expression of human and mouse secondary neural progenitor cells. The goal is to establish IL-6 as a key target for intervention to prevent neurodevelopmental disorders like...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $127,557 to the University of California, Davis to conduct research on brain aging in adults with autism spectrum disorder (ASD). The 2-year project aims to characterize age-related changes in neuroimmune profiles, immune cell phenotypes, and neuronal inflammation in the amygdala, superior temporal gyrus, and hippocampal formation of individuals...
This $6,439,263 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) aims to determine the impact of maternal substance use on maternal immune activation, placental function, and offspring neurobehavioral development. The project will leverage the Healthy Brain and Child Development (HBCD) study to perform maternal immune profiling, placental and cord blood analysis, and novel neuroinflammation imaging on 400 pregnancies...
This Project Grant award of $175,647 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program supports a longitudinal study to investigate biobehavioral markers of prenatal resilience and their association with positive postpartum maternal mental health and well-being. The key products and services to be delivered under this 5-year award include: Assessing physiological (heart rate variability) and self-reported psychological resilience in...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will fund a study to develop a hamster model to examine the neurological and behavioral impacts on offspring born to mothers infected with SARS-CoV-2. The $240,000 award to the University of Texas Medical Branch at Galveston aims to: 1) Assess the direct effects of maternal SARS-CoV-2...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support a longitudinal, intergenerational study on the development and transmission of threat sensitivity as a risk factor for psychopathology in young children. The $681,690 award to The Children's Hospital of Philadelphia will fund a study assessing the neural, biological, and behavioral correlates of threat sensitivity in 300 mother-child dyads over a...
This Project Grant award of $452,375 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research on the role of placental neurosteroids in regulating inflammation and its impact on pregnancy and neurodevelopmental outcomes. The key objectives of this 2-year project are to: 1) investigate the interactions between endogenous placental allopregnanolone (a...

BRAIN AND BEHAVIORAL ALTERATIONS IN A NONHUMAN PRIMATE MODEL OF MATERNAL IMMUNE ACTIVATION: MPFC-AMYGDALA CIRCUITRY, NEUROINFLAMMATION, AND SOCIOEMOTIONAL DEVELOPMENT - PROPOSAL SUMMARY EXPOSURE TO VIRAL OR BACTERIAL INFECTIONS DURING PREGNANCY INCREASES RISK FOR OFFSPRING NEURODEVELOPMENTAL DISORDERS, INCLUDING AUTISM AND SCHIZOPHRENIA. GESTATIONAL BIOMARKERS INDICATE THAT THE MATERNAL IMMUNE RESPONSE PLAYS A CRITICAL ROLE IN ALTERED FETAL NEURODEVELOPMENT. OUR ABILITY TO MITIGATE THE HARMFUL EFFECTS OF MATERNAL IMMUNE ACTIVATION (MIA) ON OFFSPRING NEURODEVELOPMENT IS LIMITED BY OUR INCOMPLETE MECHANISTIC UNDERSTANDING OF THE NEUROBIOLOGICAL CHANGES ASSOCIATED WITH PRENATAL EXPOSURE TO MIA. WHILE RODENT STUDIES HAVE SHOWN SIMILARITIES BETWEEN ALTERATIONS IN BRAIN AND BEHAVIORAL DEVELOPMENT IN MIA-EXPOSED OFFSPRING AND CHANGES OBSERVED IN HUMAN NEURODEVELOPMENTAL DISORDERS, THERE ARE LIMITATIONS IN TRANSLATING THESE FINDINGS TO HUMAN NEUROANATOMY AND PHYSIOLOGY. IT IS THEREFORE NECESSARY TO EXPAND THIS RESEARCH TO A PRECLINICAL MODEL MORE CLOSELY RELATED TO HUMANS, SUCH AS NONHUMAN PRIMATES (NHPS). MY PRIMARY MENTOR'S LABORATORY (BAUMAN) HAS DEVELOPED THE FIRST VIRAL-MIMIC BASED RHESUS MACAQUE MODEL OF MIA EXPOSURE IN PREGNANCY. FOR THIS K01 CAREER DEVELOPMENT AWARD, I PROPOSE TO LEVERAGE THE ENTIRETY OF BIOBEHAVIORAL DATA AVAILABLE FOR THE NHP MIA MODEL TO EXAMINE THE EFFECTS OF NEUROIMMUNE CHANGES ON BEHAVIORAL AND BRAIN ALTERATIONS IN MIA-EXPOSED NHPS. MY OUTSTANDING MENTORSHIP TEAM WILL PROVIDE FOUNDATIONAL TRAINING IN IMMUNOLOGY (VAN DE WATER) AND THE USE OF NHP MODELS (BAUMAN) TO ACCELERATE COMPLEX TRANSLATIONAL BIOMEDICAL RESEARCH IN NEURODEVELOPMENTAL DISORDERS (SCHUMANN). THIS AWARD, WHICH REPRESENTS A CRITICAL NEXT STEP IN MY DEVELOPMENT AS AN INDEPENDENT RESEARCH SCIENTIST, PROVIDES AN OPPORTUNITY TO MAKE USE OF MY UNIQUE SKILL SET IN HUMAN AND NHP CELLULAR AND MOLECULAR NEUROANATOMY, WHILE EXPANDING THE BREADTH OF MY RESEARCH FOCI IN THE UNIQUE INSTITUTIONAL ENVIRONMENT PROVIDED BY UC DAVIS AND THE CALIFORNIA NATIONAL PRIMATE RESEARCH CENTER. OUR RESEARCH WILL CONTRIBUTE TO OUR UNDERSTANDING OF THE BEHAVIORAL AND NEUROBIOLOGICAL CHANGES ASSOCIATED WITH PRENATAL EXPOSURE TO MIA. SPECIFICALLY, WE WILL APPLY NOVEL BEHAVIORAL PHENOTYPING PARADIGMS TO EVALUATE ALTERATIONS IN SOCIOEMOTIONAL BEHAVIOR IN THE MIA-EXPOSED NHP (AIM 1A). WE WILL LONGITUDINALLY MAP THE DEVELOPMENT OF THE AMYGDALA IN MIA-EXPOSED NHPS AND CONTROLS TO UNDERSTAND THE COURSE OF MIA- INDUCED STRUCTURAL BRAIN CHANGES (AIM 1B). USING POSTMORTEM TISSUE COLLECTED FROM SUBJECTS AT TWO CRITICAL AGE TIME POINTS, WE WILL EXAMINE NEUROIMMUNE PROTEOMIC ALTERATIONS IN THE AMYGDALA AND MEDIAL PREFRONTAL CORTEX (AIM 2A). USING MARKERS FOR NEUROIMMUNE TARGETS IDENTIFIED IN AIM 2A, WE WILL MAP THE EXPRESSION OF NEUROIMMUNE TRANSCRIPTS IN SPECIFIC CELL TYPES IN BRAIN TISSUE SECTIONS (AIM 2B). TOGETHER, THESE DATA BUILD A COMPREHENSIVE PICTURE OF MIA-INDUCED CHANGES IN NHP BRAIN CIRCUITRY, TOWARD THE ULTIMATE GOAL OF IDENTIFYING PATHWAYS OF VULNERABILITY AND CRITICAL PERIODS FOR NOVEL, TARGETED INTERVENTIONS AND BIOTHERAPEUTICS.

Posted 8/1/24